AbCellera Biologics Inc. ABCL Effect of exchange rate changes on cash, cash equivalents and restricted cash
Effect of exchange rate changes on cash, cash equivalents and restricted cash at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s effect of exchange rate changes on cash, cash equivalents and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s effect of exchange rate changes on cash, cash equivalents and restricted cash?
- AbCellera Biologics Inc. (ABCL) reported effect of exchange rate changes on cash, cash equivalents and restricted cash of -$38K in Q1 2026.
- How has AbCellera Biologics Inc.'s effect of exchange rate changes on cash, cash equivalents and restricted cash changed year-over-year?
- AbCellera Biologics Inc.'s effect of exchange rate changes on cash, cash equivalents and restricted cash decreased by 106.4% year-over-year, from $590K to -$38K.
- What does effect of exchange rate changes on cash, cash equivalents and restricted cash mean?
- This metric quantifies the impact of fluctuations in foreign currency exchange rates on the reported value of cash and cash equivalents held in non-functional currencies. It serves as a measure of exposure to international currency volatility.